The FDA rejected a drug that is meant to boost a woman's libido. Sprout Pharmaceuticals says it's at an impasse with the agency over the company's pink pill, Flibanserin, leaving the 15-year search for a 'female Viagra' in limbo. (Dec. 12) (01:31)
All site contents © Copyright 2013 The Washington Times, LLC. Contributors are responsible for this content, which is not edited by The Washington Times.
About Us |
Write For Us |
Contact Us |